Tevard Biosciences is a biotechnology company pioneering tRNA-based gene therapies to cure rare and severe genetic diseases with limited or no approved treatment options.

Biotechnology

Tevard Biosciences

Tevard Biosciences' headquarters in Cambridge, MA, United States

Daniel Fischer

Paul Kaplan

Paul Kaplan, PhD, MBA

Daniel Lazzari

Ben Deverman

Jeffrey Walsh

Geoffrey Pitt

Harvey Lodish

Paul Schimmel

Nicholas Ingolia

Susan Ackerman

David Liu

Orrin Devinsky

Gopi Shanker

Al George

Jeff Coller

Annapurna Poduri

Lita Nelsen

Warren Lammert

Stephen Farr

Lawrence Olanoff

Amy Salzhauer

Zoya Ignatova

The Scientific and Research Team at Tevard Biosciences focuses on pioneering advancements in tRNA-based gene therapies. This team conducts cutting-edge research to develop novel treatments for rare and severe genetic diseases. They contribute their extensive expertise in RNA biology, drug discovery, and therapeutic development to create effective solutions where no approved treatments currently exist.

Scientific and Research Team

The Leadership Team at Tevard Biosciences is responsible for steering the company's strategic vision and operational direction. Comprising experienced executives and co-founders, the team focuses on financial oversight, scientific advisory guidance, and fostering partnerships to advance innovative tRNA-based gene therapies aimed at addressing rare genetic diseases. Through collaboration and expert leadership, they work to drive the company’s mission of delivering transformative treatment options to underserved patient populations.

Leadership Team

Tevard Biosciences

Org chart

Board & advisors

Teams

Scientific and Research Team

Leadership Team

Offices

Tevard Biosciences

Org chart

Board & advisors

Teams

Scientific and Research Team

Leadership Team

Offices

Related companies